Literature DB >> 22835558

Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer.

Anthony W Kim1, Frank C Detterbeck, Daniel J Boffa, Roy H Decker, Pamela R Soulos, Laura D Cramer, Cary P Gross.   

Abstract

BACKGROUND: Racial disparities in access to surgical resection for treatment of early-stage non-small-cell lung cancer (NSCLC) are well documented. However it is unclear how race, clinical, and hospital characteristics affect the surgical approach among patients undergoing resection.
METHODS: Using the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER)/Medicare linked database, we identified patients 67 years of age or older diagnosed with stage I NSCLC who underwent surgical resection from 2000 to 2007. Surgical approach was categorized as lobectomy or segmentectomy (anatomic) versus wedge resection (nonanatomic). We used logistic regression to identify the association between demographic, clinical, and hospital factors and the use of nonanatomic resections.
RESULTS: There were 8,986 patients in the sample (mean age, 75 years; 53% women); 12.8% underwent nonanatomic resection. The use of nonanatomic resection increased significantly, from 11.0% in 2000 to 15.9% in 2007 (p=0.008). In multivariable analysis, race was not associated with the receipt of nonanatomic resection. Factors associated with the use of nonanatomic resections included age greater than 80 years (odds ratio [OR], 1.51; 95% confidence interval [CI], 1.15-1.98), T1a primary tumor status, chronic obstructive pulmonary disease (COPD) (OR, 1.81; 95% CI, 1.55-2.12), and volume of hospital lung resections performed (highest versus lowest hospital volume, OR, 1.58; 95% CI, 1.23-2.04). More nonanatomic resections were performed in 2007 than in 2000 (OR, 1.73; 95% CI, 1.27-2.37). After stratifying by tumor size, the temporal trend in the use of nonanatomic resection remained significant only among patients with tumors greater than 3 cm.
CONCLUSIONS: Since 2000, the use of nonanatomic resections in stage I NSCLC has increased, most significantly among patients with larger tumors. After adjusting for clinical factors, there was no relation between race and type of surgical resection.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22835558      PMCID: PMC3501201          DOI: 10.1016/j.athoracsur.2012.04.091

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  26 in total

1.  Racial differences in the treatment of early-stage lung cancer.

Authors:  P B Bach; L D Cramer; J L Warren; C B Begg
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

3.  Patterns of surgical care of lung cancer patients.

Authors:  Alex G Little; Valerie W Rusch; James A Bonner; Laurie E Gaspar; Mark R Green; W Richard Webb; Andrew K Stewart
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

4.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

5.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

6.  Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes.

Authors:  Henry S Park; Frank C Detterbeck; Daniel J Boffa; Anthony W Kim
Journal:  Ann Thorac Surg       Date:  2011-09-25       Impact factor: 4.330

7.  Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database.

Authors:  Carlos M Mery; Anastasia N Pappas; Raphael Bueno; Yolonda L Colson; Philip Linden; David J Sugarbaker; Michael T Jaklitsch
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

8.  Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.

Authors:  Amgad El-Sherif; William E Gooding; Ricardo Santos; Brian Pettiford; Peter F Ferson; Hiran C Fernando; Susan J Urda; James D Luketich; Rodney J Landreneau
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

9.  Racial differences in trust and lung cancer patients' perceptions of physician communication.

Authors:  Howard S Gordon; Richard L Street; Barbara F Sharf; P Adam Kelly; Julianne Souchek
Journal:  J Clin Oncol       Date:  2006-02-20       Impact factor: 44.544

10.  Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations.

Authors:  Peter B Bach; Edward Guadagnoli; Deborah Schrag; Nicola Schussler; Joan L Warren
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

View more
  4 in total

Review 1.  Update in lung cancer and mesothelioma 2012.

Authors:  Charles A Powell; Balazs Halmos; Serge P Nana-Sinkam
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

2.  Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer.

Authors:  James B Yu; Pamela R Soulos; Laura D Cramer; Roy H Decker; Anthony W Kim; Cary P Gross
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

3.  Short-term high-intensity rehabilitation in radically treated lung cancer: a three-armed randomized controlled trial.

Authors:  Jian Huang; Yutian Lai; Xudong Zhou; Shuangjiang Li; Jianhua Su; Mei Yang; Guowei Che
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

4.  Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.

Authors:  Christopher T Erb; Kevin W Su; Pamela R Soulos; Lynn T Tanoue; Cary P Gross
Journal:  Lung Cancer       Date:  2016-07-19       Impact factor: 5.705

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.